期刊文献+

培美曲塞联合顺铂与多西他赛联合顺铂治疗晚期非小细胞肺癌的临床疗效比较 被引量:16

暂未订购
导出
摘要 目的:比较培美曲塞联合顺铂与多西他赛联合顺铂治疗晚期非小细胞肺癌的临床疗效及不良反应。方法:将2010年8月至2012年8月我院治疗的晚期非小细胞肺癌96例随机分为两组各48例。A组给予培美曲塞联合顺铂化疗方案;B组给予多西他赛联合顺铂化疗方案。21d为一个疗程,每例患者至少化疗2个疗程。比较两组患者的临床疗效和不良反应。结果:两组治疗总有效率、患者平均生存时间和1年生存率相比差异无统计学意义(P>0.05);A组白细胞下降发生率明显低于B组(χ2=5.79,P<0.05),其余不良反应差别无统计学意义(P>0.05)。结论:培美曲塞联合顺铂治疗晚期非小细胞肺癌临床效果较好,不良反应相对较易耐受。
作者 李雅冰
出处 《中国民康医学》 2013年第24期29-30,共2页 Medical Journal of Chinese People’s Health
  • 相关文献

参考文献5

二级参考文献34

  • 1孙贵富.艾素联合奈达铂治疗中晚期非小细胞肺癌的临床研究[J].现代肿瘤医学,2008,16(11):1940-1941. 被引量:11
  • 2李龙芸.肺癌化学进展.见:孙燕,赵平主编.临床肿瘤学进展[M].北京:中国协和医科大学出版社,2005.256-274.
  • 3张力.晚期非小细胞肺癌治疗新进展.见:宋恕平,梁军,苗志敏主编.中国临床肿瘤学教育专辑(2005)[M].青岛:中国海洋大学出版社,2005.111.
  • 4Clarke SJ, Abratt R, Goedhals L, et al. Phase trial of peme- trexed disodium in chemotherapy - naive patients with ad- vanced non - small - cell lung cancer [ J ]. Ann Oncol, 2002,13(5) :737-741.
  • 5Rollins KD, Lindley C. Pemetrexed : amuhitargeted antifolate [J]. Clin Ther,2005,27(9) : 1343 - 1382.
  • 6Scagliotti GV, Parikh P, Von PJ, et al. Phase III study com- paring cisplatin plus gemcitabine with cisplatin plus peme- trexed in chemotherapy naive patients with advanced stage non small cell lung cancer [ J ]. J Clin Oncol, 2008,26 (21) :3543 -3551.
  • 7Giovannetti E, Mey V, Nannizzi S, et al. Cellular and phar- macogenetics foundation of synergistic interaction of peme- trexed and gemeitabine in human non - small cell lung cancer cells [ J ]. Mol Pharmacol, 2005,68 : 110.
  • 8Huang C, Liu D, Nakano J, et al. E2F - 1 overexpression associated with TS and surviving gene expressions in non - small cell lung cancer [ J ]. J Clin Oncol, 2007,25 (Suppl) :426s.
  • 9Ohe Y. Chemoradiotherapy for lung cancer[ J]. Expert Opin Phar- macother, 2005,6(16) :2793-2804.
  • 10Fossella F, Pereira JR, van Pawel J, et al. Randomized, multina- tional, phase I study of docetaxel plus platinum combinations ver- sus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: the TAX 326 study group [ J]. J Clin Oncol, 2003,21 (16) :3016-3024.

共引文献73

同被引文献111

  • 1谢红妹.应用多西他赛联合顺铂治疗晚期非小细胞肺癌的临床疗效观察[J].求医问药(下半月),2013(12):315-316. 被引量:2
  • 2孙永臣,刘军,杨曦,韩文杰.培美曲塞二线治疗晚期非小细胞肺癌的临床对比研究[J].中国临床实用医学,2014,0(6):54-55. 被引量:3
  • 3郝学志,张湘茹,胡兴胜,王彬,赵龙妹,黄镜.培美曲塞治疗19例复发性晚期非小细胞肺癌[J].中国癌症杂志,2007,17(7):575-577. 被引量:35
  • 4Lee DS, Kim YS, Kang JH, et al. Clinical Responses and PrognosticIndicators of Concurrent Chemoradiation for Non-small Cell LungCancer[J]. Cancer Res Treat, 2011,43(1):32-41.
  • 5Priker R, Minar W. Chemotherapy of advanced non-small cell lungcancer[J]. Front Radiat Ther Oncol, 2010,42:157-163.
  • 6Brade A, Bezjak A, Macrae R, et al. Phase I trial of radiationwithconcurrent and consolidationp emetxexed and cisplatin in patientswith unresectable stage IIIA/B non-small-cell lung cancer[J]. Int J Ra-diat Oncol Biol Phys, 2011,79(5):1395-1401.
  • 7Greenhalgh J, McLeod C, Bagust A, et al. Pemetrexed for the ma-in-tenance treatment of locally advanced or metastatic non-small celllung cancer[J]. Health Technol Assess, 2010,14(2):33-39.
  • 8Cardenal F, Amaiz MD, Mor d n T, et al. Phase I,study, of concurrentchemoradiation with pemetrexed and cisplatin followed by consolida-tion pemetrexed for patients with unresectable stage III non-small celllung cancer[J]. Lung cancer, 2011,74(1):69-74.
  • 9Paz-Ares L, De Marinis F, Dediu M, et al. Maintenance therapy withpemetrexed plus best supportive care versus placebo plus best sup-portive care after induction therapy with pemetrexed plus cisplatin foradvanced non-squamous non-small-cell lung cancer (PARA-MOUNT): a double-blind, phase 3, randomised controlled trial [J].Lancet Oncol, 2012,13(3):247-255.
  • 10Hwang KE, Kim YS, Hwang YR, et al. Enhanced apoptosis by peme-trexed and simvastatin in malignant mesothelioma and lung cancercells by reactive oxygen species-dependent mitochondrial dysfunctionand Bim induction[J]. Int J Oncol, 2014,45(4):1769-1777.

引证文献16

二级引证文献95

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部